Detalhe da pesquisa
1.
iAMPCN: a deep-learning approach for identifying antimicrobial peptides and their functional activities.
Brief Bioinform
; 24(4)2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369638
2.
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 68(4): e0108123, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376189
3.
Comprehensive stability analysis of 13 ß-lactams and ß-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation.
Antimicrob Agents Chemother
; 68(3): e0139923, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38329330
4.
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis.
Antimicrob Agents Chemother
; 67(1): e0131222, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622154
5.
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.
Antimicrob Agents Chemother
; 67(8): e0041423, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428034
6.
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.
J Antimicrob Chemother
; 78(6): 1460-1470, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071586
7.
Penetration of Vancomycin into Noninfected Bone in Patients Undergoing Total Joint Arthroplasty Evaluated by a Minimal Physiologically Based Population Pharmacokinetic Modeling Approach.
Mol Pharm
; 20(3): 1509-1518, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512679
8.
Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep.
Pharm Res
; 40(8): 1915-1925, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37498498
9.
Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and Enterobacterales.
Antimicrob Agents Chemother
; 66(2): e0144621, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807759
10.
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
Antimicrob Agents Chemother
; 66(3): e0220321, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041509
11.
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
Antimicrob Agents Chemother
; 66(10): e0059122, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125299
12.
Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.
J Antimicrob Chemother
; 77(7): 1923-1930, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470370
13.
Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses.
Antimicrob Agents Chemother
; 65(6)2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782000
14.
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model.
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366710
15.
Nanosilver Mitigates Biofilm Formation via FapC Amyloidosis Inhibition.
Small
; 16(21): e1906674, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984626
16.
Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.
J Clin Microbiol
; 58(10)2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669380
17.
Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.
Clin Infect Dis
; 69(11): 1962-1968, 2019 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30722017
18.
Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
Antimicrob Agents Chemother
; 63(11)2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427301
19.
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients.
Antimicrob Agents Chemother
; 64(1)2019 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636062
20.
Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745381